Interstitial cystitis and bladder pain syndrome (IC/BPS) vary in clinical manifestation, according to a study published online Oct. 18 in the International Journal of Urology.

Sophie Pierce is determined to make the most of her life - however long she may have.

ALYFTREK is indicated for the treatment of cystic fibrosis (CF) in patients aged 6 years and ... or ALT or AST >3x ULN with bilirubin >2x ULN) Clinical signs or symptoms suggestive of liver injury ...

Vertex Pharmaceuticals (NASDAQ: VRTX) was on track to become one of this year's biotech winners, with the shares climbing 27% ...

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Alyftrek for treatment of cystic fibrosis.

The company's portfolio includes therapies for cystic fibrosis, sickle cell disease ... or a mutation responsive to TRIKAFTA, based on clinical or in vitro data. The drug's label now encompasses ...

Keating, M.D., Co-Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program at Columbia University and investigator in the ALYFTREK clinical trial program. "ALYFTREK has the potential ...

NHS England has signed an agreement with US pharma Vertex covering all the company’s licensed cystic fibrosis medicines, and any future uses for them. The deal follows a three-year stand off ...

A case study on how a pharmaceutical company specializing in cystic fibrosis treatments turned to DelveInsight for comprehensive analysis and insights into the digital cystic fibrosis landscape in the ...

Ustad Hussain’s family, in a statement, said he died of idiopathic pulmonary fibrosis. Idiopathic pulmonary ... many people may have no symptoms. As the disease progresses, patients may ...

Chaurasia: In a great number of cases, the cause of pulmonary fibrosis couldn’t be ascertained and these are called idiopathic. What are some symptoms one should look out for in order to ensure ...